Medtronic (MDT) Net Income towards Common Stockholders (2014 - 2026)

Medtronic (MDT) has 13 years of Net Income towards Common Stockholders data on file, last reported at $1.3 billion in Q2 2026.

• For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 18.55% year-over-year to $1.3 billion; the trailing twelve-month figure through Apr 2026 stood at $4.8 billion (up 3.13% YoY), and the FY2026 full-year result was $4.8 billion, up 3.09% from the prior year.
• Net Income towards Common Stockholders grew to $1.3 billion in Q2 2026, from $1.2 billion in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $1.5 billion in Q2 2022 to a low of $436.0 million in Q4 2022.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2023 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders slumped 66.89% in 2022 and surged 108.94% in 2023, its largest moves.
• Tracing MDT's Net Income towards Common Stockholders over 5 years: stood at $436.0 million in 2022, then surged by 108.94% to $911.0 million in 2023, then jumped by 40.29% to $1.3 billion in 2024, then increased by 8.14% to $1.4 billion in 2025, then slipped by 8.9% to $1.3 billion in 2026.
• Business Quant data shows MDT's Net Income towards Common Stockholders at $1.3 billion in Q2 2026, $1.2 billion in Q1 2026, and $1.4 billion in Q4 2025.